[HTML][HTML] Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative Care, 2015 - Springer
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients involvement in specific therapies decision …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative …, 2015 - search.proquest.com
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
[PDF][PDF] Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies …
Y Beaussant, F Mathieu-Nicot, L Pazart, C Tournigand… - 2015 - cyberleninka.org
Background: Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
[PDF][PDF] Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies …
Y Beaussant, F Mathieu-Nicot, L Pazart, C Tournigand… - 2015 - researchgate.net
Background: Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC palliative …, 2015 - pubmed.ncbi.nlm.nih.gov
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
[HTML][HTML] Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies …
Y Beaussant, F Mathieu-Nicot… - BMC …, 2015 - bmcpalliatcare.biomedcentral.com
Little is known about what is at stake at a subjective level for the oncologists and the
advanced cancer patients when they face the question whether to continue, limit or stop …
advanced cancer patients when they face the question whether to continue, limit or stop …
[HTML][HTML] Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative …, 2015 - ncbi.nlm.nih.gov
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative …, 2015 - europepmc.org
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative …, 2015 - go.gale.com
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …
Is shared decision-making vanishing at the end-of-life? A descriptive and qualitative study of advanced cancer patients' involvement in specific therapies decision …
Y Beaussant, F Mathieu-Nicot, L Pazart… - BMC Palliative Care, 2015 - infona.pl
Background Little is known about what is at stake at a subjective level for the oncologists
and the advanced cancer patients when they face the question whether to continue, limit or …
and the advanced cancer patients when they face the question whether to continue, limit or …